nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—hematologic cancer	0.187	1	CbGaD
Ergonovine—ABCB1—Lenalidomide—hematologic cancer	0.0393	0.0698	CbGbCtD
Ergonovine—CYP3A4—Bexarotene—hematologic cancer	0.0235	0.0418	CbGbCtD
Ergonovine—ABCB1—Daunorubicin—hematologic cancer	0.023	0.0409	CbGbCtD
Ergonovine—ABCB1—Alitretinoin—hematologic cancer	0.0226	0.0401	CbGbCtD
Ergonovine—CYP3A4—Busulfan—hematologic cancer	0.0219	0.0389	CbGbCtD
Ergonovine—CYP3A4—Lomustine—hematologic cancer	0.0219	0.0389	CbGbCtD
Ergonovine—CYP3A4—Thiotepa—hematologic cancer	0.0195	0.0347	CbGbCtD
Ergonovine—ABCB1—Imatinib—hematologic cancer	0.0176	0.0314	CbGbCtD
Ergonovine—ABCB1—Nilotinib—hematologic cancer	0.016	0.0285	CbGbCtD
Ergonovine—ABCB1—Vinorelbine—hematologic cancer	0.0159	0.0283	CbGbCtD
Ergonovine—CYP3A4—Methoxsalen—hematologic cancer	0.0152	0.027	CbGbCtD
Ergonovine—CYP3A4—Bortezomib—hematologic cancer	0.0144	0.0256	CbGbCtD
Ergonovine—ABCB1—Dasatinib—hematologic cancer	0.0142	0.0252	CbGbCtD
Ergonovine—ABCB1—Mitoxantrone—hematologic cancer	0.014	0.0249	CbGbCtD
Ergonovine—CYP3A4—Daunorubicin—hematologic cancer	0.0138	0.0245	CbGbCtD
Ergonovine—ABCB1—Betamethasone—hematologic cancer	0.0125	0.0222	CbGbCtD
Ergonovine—ABCB1—Gemcitabine—hematologic cancer	0.0124	0.022	CbGbCtD
Ergonovine—ABCB1—Prednisolone—hematologic cancer	0.0123	0.0219	CbGbCtD
Ergonovine—CYP3A4—Cytarabine—hematologic cancer	0.0122	0.0216	CbGbCtD
Ergonovine—CYP3A4—Teniposide—hematologic cancer	0.012	0.0213	CbGbCtD
Ergonovine—ABCB1—Prednisone—hematologic cancer	0.0116	0.0207	CbGbCtD
Ergonovine—CYP3A4—Ifosfamide—hematologic cancer	0.0111	0.0197	CbGbCtD
Ergonovine—ABCB1—Irinotecan—hematologic cancer	0.011	0.0196	CbGbCtD
Ergonovine—CYP3A4—Imatinib—hematologic cancer	0.0106	0.0188	CbGbCtD
Ergonovine—CYP3A4—Ruxolitinib—hematologic cancer	0.00995	0.0177	CbGbCtD
Ergonovine—ABCB1—Vinblastine—hematologic cancer	0.00979	0.0174	CbGbCtD
Ergonovine—ABCB1—Vincristine—hematologic cancer	0.00963	0.0171	CbGbCtD
Ergonovine—CYP3A4—Nilotinib—hematologic cancer	0.0096	0.0171	CbGbCtD
Ergonovine—CYP3A4—Vinorelbine—hematologic cancer	0.00952	0.0169	CbGbCtD
Ergonovine—ABCB1—Cisplatin—hematologic cancer	0.00898	0.016	CbGbCtD
Ergonovine—ABCB1—Etoposide—hematologic cancer	0.00882	0.0157	CbGbCtD
Ergonovine—CYP3A4—Triamcinolone—hematologic cancer	0.00871	0.0155	CbGbCtD
Ergonovine—CYP3A4—Dasatinib—hematologic cancer	0.00848	0.0151	CbGbCtD
Ergonovine—CYP3A4—Mitoxantrone—hematologic cancer	0.00838	0.0149	CbGbCtD
Ergonovine—CYP3A4—Betamethasone—hematologic cancer	0.00747	0.0133	CbGbCtD
Ergonovine—CYP3A4—Prednisolone—hematologic cancer	0.00737	0.0131	CbGbCtD
Ergonovine—ABCB1—Dexamethasone—hematologic cancer	0.00725	0.0129	CbGbCtD
Ergonovine—CYP3A4—Prednisone—hematologic cancer	0.00696	0.0124	CbGbCtD
Ergonovine—CYP3A4—Irinotecan—hematologic cancer	0.0066	0.0117	CbGbCtD
Ergonovine—ABCB1—Doxorubicin—hematologic cancer	0.00602	0.0107	CbGbCtD
Ergonovine—CYP3A4—Vinblastine—hematologic cancer	0.00587	0.0104	CbGbCtD
Ergonovine—ABCB1—Methotrexate—hematologic cancer	0.00583	0.0104	CbGbCtD
Ergonovine—CYP3A4—Vincristine—hematologic cancer	0.00577	0.0103	CbGbCtD
Ergonovine—CYP3A4—Etoposide—hematologic cancer	0.00528	0.0094	CbGbCtD
Ergonovine—CYP3A4—Dexamethasone—hematologic cancer	0.00435	0.00773	CbGbCtD
Ergonovine—CYP3A4—Doxorubicin—hematologic cancer	0.0036	0.00641	CbGbCtD
Ergonovine—Gastrointestinal pain—Vinorelbine—hematologic cancer	0.000177	0.000901	CcSEcCtD
Ergonovine—Vomiting—Nilotinib—hematologic cancer	0.000177	0.0009	CcSEcCtD
Ergonovine—Vomiting—Imatinib—hematologic cancer	0.000176	0.000895	CcSEcCtD
Ergonovine—Hypotension—Ifosfamide—hematologic cancer	0.000176	0.000894	CcSEcCtD
Ergonovine—Shock—Mitoxantrone—hematologic cancer	0.000176	0.000894	CcSEcCtD
Ergonovine—Shock—Irinotecan—hematologic cancer	0.000176	0.000894	CcSEcCtD
Ergonovine—Abdominal pain—Bortezomib—hematologic cancer	0.000175	0.000892	CcSEcCtD
Ergonovine—Bradycardia—Betamethasone—hematologic cancer	0.000175	0.000891	CcSEcCtD
Ergonovine—Bradycardia—Dexamethasone—hematologic cancer	0.000175	0.000891	CcSEcCtD
Ergonovine—Muscle spasms—Etoposide—hematologic cancer	0.000175	0.00089	CcSEcCtD
Ergonovine—Headache—Nilotinib—hematologic cancer	0.000174	0.000886	CcSEcCtD
Ergonovine—Headache—Imatinib—hematologic cancer	0.000173	0.000881	CcSEcCtD
Ergonovine—Vomiting—Cladribine—hematologic cancer	0.000173	0.000879	CcSEcCtD
Ergonovine—Hyperhidrosis—Irinotecan—hematologic cancer	0.000173	0.000879	CcSEcCtD
Ergonovine—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000173	0.000879	CcSEcCtD
Ergonovine—Dizziness—Vinblastine—hematologic cancer	0.000172	0.000877	CcSEcCtD
Ergonovine—Hypotension—Vincristine—hematologic cancer	0.000171	0.000872	CcSEcCtD
Ergonovine—Dyspnoea—Carmustine—hematologic cancer	0.000171	0.000871	CcSEcCtD
Ergonovine—Hallucination—Dexamethasone—hematologic cancer	0.000171	0.000871	CcSEcCtD
Ergonovine—Hallucination—Betamethasone—hematologic cancer	0.000171	0.000871	CcSEcCtD
Ergonovine—Abdominal pain—Vinorelbine—hematologic cancer	0.000171	0.000871	CcSEcCtD
Ergonovine—Headache—Cladribine—hematologic cancer	0.00017	0.000866	CcSEcCtD
Ergonovine—Dyspnoea—Alitretinoin—hematologic cancer	0.00017	0.000863	CcSEcCtD
Ergonovine—Diarrhoea—Melphalan—hematologic cancer	0.00017	0.000863	CcSEcCtD
Ergonovine—Gastrointestinal pain—Thiotepa—hematologic cancer	0.000169	0.000861	CcSEcCtD
Ergonovine—Nausea—Chlorambucil—hematologic cancer	0.000169	0.000859	CcSEcCtD
Ergonovine—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000168	0.000856	CcSEcCtD
Ergonovine—Dyspnoea—Ifosfamide—hematologic cancer	0.000168	0.000853	CcSEcCtD
Ergonovine—Hypotension—Mitoxantrone—hematologic cancer	0.000167	0.000849	CcSEcCtD
Ergonovine—Hypotension—Irinotecan—hematologic cancer	0.000167	0.000849	CcSEcCtD
Ergonovine—Vomiting—Vinblastine—hematologic cancer	0.000166	0.000843	CcSEcCtD
Ergonovine—Nausea—Nilotinib—hematologic cancer	0.000165	0.000841	CcSEcCtD
Ergonovine—Diarrhoea—Lenalidomide—hematologic cancer	0.000165	0.000839	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisone—hematologic cancer	0.000165	0.000837	CcSEcCtD
Ergonovine—Nausea—Imatinib—hematologic cancer	0.000164	0.000836	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisone—hematologic cancer	0.000164	0.000833	CcSEcCtD
Ergonovine—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000164	0.000832	CcSEcCtD
Ergonovine—Vertigo—Etoposide—hematologic cancer	0.000164	0.000832	CcSEcCtD
Ergonovine—Abdominal pain—Thiotepa—hematologic cancer	0.000164	0.000832	CcSEcCtD
Ergonovine—Headache—Vinblastine—hematologic cancer	0.000163	0.000831	CcSEcCtD
Ergonovine—Diarrhoea—Hydroxyurea—hematologic cancer	0.000163	0.000827	CcSEcCtD
Ergonovine—Hypotension—Gemcitabine—hematologic cancer	0.000163	0.000827	CcSEcCtD
Ergonovine—Nausea—Cladribine—hematologic cancer	0.000161	0.000821	CcSEcCtD
Ergonovine—Vertigo—Prednisolone—hematologic cancer	0.000161	0.000821	CcSEcCtD
Ergonovine—Dizziness—Lenalidomide—hematologic cancer	0.000159	0.000811	CcSEcCtD
Ergonovine—Dyspnoea—Mitoxantrone—hematologic cancer	0.000159	0.00081	CcSEcCtD
Ergonovine—Dyspnoea—Irinotecan—hematologic cancer	0.000159	0.00081	CcSEcCtD
Ergonovine—Abdominal pain—Thalidomide—hematologic cancer	0.000158	0.000805	CcSEcCtD
Ergonovine—Vomiting—Melphalan—hematologic cancer	0.000158	0.000802	CcSEcCtD
Ergonovine—Hypertension—Etoposide—hematologic cancer	0.000157	0.0008	CcSEcCtD
Ergonovine—Dizziness—Hydroxyurea—hematologic cancer	0.000157	0.0008	CcSEcCtD
Ergonovine—Gastrointestinal pain—Carmustine—hematologic cancer	0.000157	0.000799	CcSEcCtD
Ergonovine—Hyperhidrosis—Cisplatin—hematologic cancer	0.000157	0.000798	CcSEcCtD
Ergonovine—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000156	0.000792	CcSEcCtD
Ergonovine—Dyspnoea—Gemcitabine—hematologic cancer	0.000155	0.000789	CcSEcCtD
Ergonovine—Hypertension—Prednisolone—hematologic cancer	0.000155	0.000789	CcSEcCtD
Ergonovine—Chest pain—Etoposide—hematologic cancer	0.000155	0.000789	CcSEcCtD
Ergonovine—Nausea—Vinblastine—hematologic cancer	0.000155	0.000788	CcSEcCtD
Ergonovine—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000154	0.000783	CcSEcCtD
Ergonovine—Vomiting—Lenalidomide—hematologic cancer	0.000153	0.00078	CcSEcCtD
Ergonovine—Bradycardia—Prednisone—hematologic cancer	0.000153	0.000776	CcSEcCtD
Ergonovine—Abdominal pain—Carmustine—hematologic cancer	0.000152	0.000773	CcSEcCtD
Ergonovine—Diarrhoea—Bortezomib—hematologic cancer	0.000152	0.000772	CcSEcCtD
Ergonovine—Hypotension—Cisplatin—hematologic cancer	0.000152	0.000771	CcSEcCtD
Ergonovine—Vomiting—Hydroxyurea—hematologic cancer	0.000151	0.000769	CcSEcCtD
Ergonovine—Headache—Lenalidomide—hematologic cancer	0.000151	0.000768	CcSEcCtD
Ergonovine—Abdominal pain—Alitretinoin—hematologic cancer	0.00015	0.000766	CcSEcCtD
Ergonovine—Gastrointestinal pain—Vincristine—hematologic cancer	0.00015	0.000763	CcSEcCtD
Ergonovine—Hallucination—Prednisone—hematologic cancer	0.000149	0.000759	CcSEcCtD
Ergonovine—Headache—Hydroxyurea—hematologic cancer	0.000149	0.000758	CcSEcCtD
Ergonovine—Abdominal pain—Ifosfamide—hematologic cancer	0.000149	0.000757	CcSEcCtD
Ergonovine—Vertigo—Triamcinolone—hematologic cancer	0.000148	0.000755	CcSEcCtD
Ergonovine—Diarrhoea—Vinorelbine—hematologic cancer	0.000148	0.000754	CcSEcCtD
Ergonovine—Nausea—Melphalan—hematologic cancer	0.000147	0.000749	CcSEcCtD
Ergonovine—Dizziness—Bortezomib—hematologic cancer	0.000147	0.000746	CcSEcCtD
Ergonovine—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000146	0.000743	CcSEcCtD
Ergonovine—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000146	0.000743	CcSEcCtD
Ergonovine—Abdominal pain—Vincristine—hematologic cancer	0.000145	0.000738	CcSEcCtD
Ergonovine—Dyspnoea—Cisplatin—hematologic cancer	0.000145	0.000736	CcSEcCtD
Ergonovine—Shock—Prednisolone—hematologic cancer	0.000144	0.000734	CcSEcCtD
Ergonovine—Hyperhidrosis—Etoposide—hematologic cancer	0.000144	0.000731	CcSEcCtD
Ergonovine—Dizziness—Vinorelbine—hematologic cancer	0.000143	0.000729	CcSEcCtD
Ergonovine—Nausea—Lenalidomide—hematologic cancer	0.000143	0.000728	CcSEcCtD
Ergonovine—Hypertension—Triamcinolone—hematologic cancer	0.000143	0.000725	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000142	0.000721	CcSEcCtD
Ergonovine—Diarrhoea—Thiotepa—hematologic cancer	0.000142	0.00072	CcSEcCtD
Ergonovine—Abdominal pain—Mitoxantrone—hematologic cancer	0.000141	0.000718	CcSEcCtD
Ergonovine—Abdominal pain—Irinotecan—hematologic cancer	0.000141	0.000718	CcSEcCtD
Ergonovine—Nausea—Hydroxyurea—hematologic cancer	0.000141	0.000718	CcSEcCtD
Ergonovine—Vomiting—Bortezomib—hematologic cancer	0.000141	0.000718	CcSEcCtD
Ergonovine—Vomiting—Bleomycin—hematologic cancer	0.00014	0.000712	CcSEcCtD
Ergonovine—Headache—Bortezomib—hematologic cancer	0.000139	0.000707	CcSEcCtD
Ergonovine—Hypotension—Etoposide—hematologic cancer	0.000139	0.000706	CcSEcCtD
Ergonovine—Vomiting—Vinorelbine—hematologic cancer	0.000138	0.000701	CcSEcCtD
Ergonovine—Diarrhoea—Thalidomide—hematologic cancer	0.000137	0.000696	CcSEcCtD
Ergonovine—Dizziness—Thiotepa—hematologic cancer	0.000137	0.000696	CcSEcCtD
Ergonovine—Headache—Vinorelbine—hematologic cancer	0.000136	0.00069	CcSEcCtD
Ergonovine—Vertigo—Dexamethasone—hematologic cancer	0.000135	0.000685	CcSEcCtD
Ergonovine—Vertigo—Betamethasone—hematologic cancer	0.000135	0.000685	CcSEcCtD
Ergonovine—Sweating—Methotrexate—hematologic cancer	0.000134	0.000681	CcSEcCtD
Ergonovine—Haematuria—Methotrexate—hematologic cancer	0.000133	0.000677	CcSEcCtD
Ergonovine—Shock—Triamcinolone—hematologic cancer	0.000133	0.000675	CcSEcCtD
Ergonovine—Dyspnoea—Etoposide—hematologic cancer	0.000132	0.000674	CcSEcCtD
Ergonovine—Dizziness—Thalidomide—hematologic cancer	0.000132	0.000673	CcSEcCtD
Ergonovine—Nausea—Bortezomib—hematologic cancer	0.000132	0.00067	CcSEcCtD
Ergonovine—Vomiting—Thiotepa—hematologic cancer	0.000132	0.000669	CcSEcCtD
Ergonovine—Diarrhoea—Carmustine—hematologic cancer	0.000131	0.000669	CcSEcCtD
Ergonovine—Nausea—Bleomycin—hematologic cancer	0.000131	0.000665	CcSEcCtD
Ergonovine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.00013	0.000663	CcSEcCtD
Ergonovine—Diarrhoea—Alitretinoin—hematologic cancer	0.00013	0.000663	CcSEcCtD
Ergonovine—Headache—Thiotepa—hematologic cancer	0.00013	0.000659	CcSEcCtD
Ergonovine—Hypertension—Dexamethasone—hematologic cancer	0.000129	0.000658	CcSEcCtD
Ergonovine—Hypertension—Betamethasone—hematologic cancer	0.000129	0.000658	CcSEcCtD
Ergonovine—Diarrhoea—Ifosfamide—hematologic cancer	0.000129	0.000655	CcSEcCtD
Ergonovine—Nausea—Vinorelbine—hematologic cancer	0.000129	0.000655	CcSEcCtD
Ergonovine—Vomiting—Thalidomide—hematologic cancer	0.000127	0.000647	CcSEcCtD
Ergonovine—Dizziness—Carmustine—hematologic cancer	0.000127	0.000646	CcSEcCtD
Ergonovine—Dizziness—Alitretinoin—hematologic cancer	0.000126	0.00064	CcSEcCtD
Ergonovine—Diarrhoea—Vincristine—hematologic cancer	0.000126	0.000638	CcSEcCtD
Ergonovine—Headache—Thalidomide—hematologic cancer	0.000125	0.000638	CcSEcCtD
Ergonovine—Sweating—Epirubicin—hematologic cancer	0.000125	0.000637	CcSEcCtD
Ergonovine—Haematuria—Epirubicin—hematologic cancer	0.000125	0.000633	CcSEcCtD
Ergonovine—Dizziness—Ifosfamide—hematologic cancer	0.000124	0.000633	CcSEcCtD
Ergonovine—Nausea—Thiotepa—hematologic cancer	0.000123	0.000625	CcSEcCtD
Ergonovine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000122	0.000622	CcSEcCtD
Ergonovine—Diarrhoea—Irinotecan—hematologic cancer	0.000122	0.000622	CcSEcCtD
Ergonovine—Vomiting—Carmustine—hematologic cancer	0.000122	0.000622	CcSEcCtD
Ergonovine—Gastrointestinal pain—Etoposide—hematologic cancer	0.000122	0.000618	CcSEcCtD
Ergonovine—Dizziness—Vincristine—hematologic cancer	0.000121	0.000617	CcSEcCtD
Ergonovine—Vomiting—Alitretinoin—hematologic cancer	0.000121	0.000616	CcSEcCtD
Ergonovine—Headache—Carmustine—hematologic cancer	0.00012	0.000612	CcSEcCtD
Ergonovine—Shock—Dexamethasone—hematologic cancer	0.00012	0.000612	CcSEcCtD
Ergonovine—Shock—Betamethasone—hematologic cancer	0.00012	0.000612	CcSEcCtD
Ergonovine—Dyspnoea—Triamcinolone—hematologic cancer	0.00012	0.000611	CcSEcCtD
Ergonovine—Vomiting—Ifosfamide—hematologic cancer	0.00012	0.000609	CcSEcCtD
Ergonovine—Bradycardia—Epirubicin—hematologic cancer	0.000119	0.000607	CcSEcCtD
Ergonovine—Headache—Alitretinoin—hematologic cancer	0.000119	0.000607	CcSEcCtD
Ergonovine—Diarrhoea—Gemcitabine—hematologic cancer	0.000119	0.000606	CcSEcCtD
Ergonovine—Nausea—Thalidomide—hematologic cancer	0.000119	0.000605	CcSEcCtD
Ergonovine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000118	0.000601	CcSEcCtD
Ergonovine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000118	0.000601	CcSEcCtD
Ergonovine—Dizziness—Irinotecan—hematologic cancer	0.000118	0.000601	CcSEcCtD
Ergonovine—Abdominal pain—Etoposide—hematologic cancer	0.000117	0.000598	CcSEcCtD
Ergonovine—Vertigo—Prednisone—hematologic cancer	0.000117	0.000596	CcSEcCtD
Ergonovine—Tinnitus—Methotrexate—hematologic cancer	0.000117	0.000594	CcSEcCtD
Ergonovine—Vomiting—Vincristine—hematologic cancer	0.000117	0.000593	CcSEcCtD
Ergonovine—Sweating—Doxorubicin—hematologic cancer	0.000116	0.000589	CcSEcCtD
Ergonovine—Haematuria—Doxorubicin—hematologic cancer	0.000115	0.000586	CcSEcCtD
Ergonovine—Headache—Vincristine—hematologic cancer	0.000115	0.000585	CcSEcCtD
Ergonovine—Hypotension—Dexamethasone—hematologic cancer	0.000114	0.000581	CcSEcCtD
Ergonovine—Hypotension—Betamethasone—hematologic cancer	0.000114	0.000581	CcSEcCtD
Ergonovine—Nausea—Carmustine—hematologic cancer	0.000114	0.000581	CcSEcCtD
Ergonovine—Vomiting—Mitoxantrone—hematologic cancer	0.000114	0.000578	CcSEcCtD
Ergonovine—Vomiting—Irinotecan—hematologic cancer	0.000114	0.000578	CcSEcCtD
Ergonovine—Nausea—Alitretinoin—hematologic cancer	0.000113	0.000575	CcSEcCtD
Ergonovine—Hypertension—Prednisone—hematologic cancer	0.000113	0.000573	CcSEcCtD
Ergonovine—Headache—Irinotecan—hematologic cancer	0.000112	0.000569	CcSEcCtD
Ergonovine—Headache—Mitoxantrone—hematologic cancer	0.000112	0.000569	CcSEcCtD
Ergonovine—Nausea—Ifosfamide—hematologic cancer	0.000112	0.000568	CcSEcCtD
Ergonovine—Diarrhoea—Cisplatin—hematologic cancer	0.000111	0.000565	CcSEcCtD
Ergonovine—Vomiting—Gemcitabine—hematologic cancer	0.000111	0.000563	CcSEcCtD
Ergonovine—Bradycardia—Doxorubicin—hematologic cancer	0.00011	0.000562	CcSEcCtD
Ergonovine—Tinnitus—Epirubicin—hematologic cancer	0.000109	0.000556	CcSEcCtD
Ergonovine—Headache—Gemcitabine—hematologic cancer	0.000109	0.000555	CcSEcCtD
Ergonovine—Nausea—Vincristine—hematologic cancer	0.000109	0.000554	CcSEcCtD
Ergonovine—Nausea—Mitoxantrone—hematologic cancer	0.000106	0.00054	CcSEcCtD
Ergonovine—Nausea—Irinotecan—hematologic cancer	0.000106	0.00054	CcSEcCtD
Ergonovine—Shock—Prednisone—hematologic cancer	0.000105	0.000533	CcSEcCtD
Ergonovine—Nausea—Gemcitabine—hematologic cancer	0.000103	0.000526	CcSEcCtD
Ergonovine—Vomiting—Cisplatin—hematologic cancer	0.000103	0.000525	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisone—hematologic cancer	0.000103	0.000524	CcSEcCtD
Ergonovine—Diarrhoea—Etoposide—hematologic cancer	0.000102	0.000517	CcSEcCtD
Ergonovine—Tinnitus—Doxorubicin—hematologic cancer	0.000101	0.000515	CcSEcCtD
Ergonovine—Gastrointestinal pain—Betamethasone—hematologic cancer	0.0001	0.000509	CcSEcCtD
Ergonovine—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.0001	0.000509	CcSEcCtD
Ergonovine—Dizziness—Etoposide—hematologic cancer	9.83e-05	0.0005	CcSEcCtD
Ergonovine—Muscle spasms—Epirubicin—hematologic cancer	9.81e-05	0.000499	CcSEcCtD
Ergonovine—Vertigo—Methotrexate—hematologic cancer	9.8e-05	0.000498	CcSEcCtD
Ergonovine—Dizziness—Prednisolone—hematologic cancer	9.69e-05	0.000493	CcSEcCtD
Ergonovine—Abdominal pain—Dexamethasone—hematologic cancer	9.67e-05	0.000492	CcSEcCtD
Ergonovine—Abdominal pain—Betamethasone—hematologic cancer	9.67e-05	0.000492	CcSEcCtD
Ergonovine—Nausea—Cisplatin—hematologic cancer	9.63e-05	0.00049	CcSEcCtD
Ergonovine—Vomiting—Etoposide—hematologic cancer	9.45e-05	0.000481	CcSEcCtD
Ergonovine—Headache—Etoposide—hematologic cancer	9.31e-05	0.000474	CcSEcCtD
Ergonovine—Chest pain—Methotrexate—hematologic cancer	9.28e-05	0.000472	CcSEcCtD
Ergonovine—Headache—Prednisolone—hematologic cancer	9.18e-05	0.000467	CcSEcCtD
Ergonovine—Vertigo—Epirubicin—hematologic cancer	9.17e-05	0.000466	CcSEcCtD
Ergonovine—Muscle spasms—Doxorubicin—hematologic cancer	9.08e-05	0.000462	CcSEcCtD
Ergonovine—Palpitations—Epirubicin—hematologic cancer	9.02e-05	0.000459	CcSEcCtD
Ergonovine—Dizziness—Triamcinolone—hematologic cancer	8.91e-05	0.000453	CcSEcCtD
Ergonovine—Nausea—Etoposide—hematologic cancer	8.83e-05	0.000449	CcSEcCtD
Ergonovine—Hypertension—Epirubicin—hematologic cancer	8.81e-05	0.000448	CcSEcCtD
Ergonovine—Gastrointestinal pain—Prednisone—hematologic cancer	8.71e-05	0.000443	CcSEcCtD
Ergonovine—Nausea—Prednisolone—hematologic cancer	8.71e-05	0.000443	CcSEcCtD
Ergonovine—Chest pain—Epirubicin—hematologic cancer	8.69e-05	0.000442	CcSEcCtD
Ergonovine—Hyperhidrosis—Methotrexate—hematologic cancer	8.6e-05	0.000438	CcSEcCtD
Ergonovine—Vomiting—Triamcinolone—hematologic cancer	8.57e-05	0.000436	CcSEcCtD
Ergonovine—Vertigo—Doxorubicin—hematologic cancer	8.48e-05	0.000432	CcSEcCtD
Ergonovine—Headache—Triamcinolone—hematologic cancer	8.44e-05	0.00043	CcSEcCtD
Ergonovine—Abdominal pain—Prednisone—hematologic cancer	8.42e-05	0.000428	CcSEcCtD
Ergonovine—Diarrhoea—Betamethasone—hematologic cancer	8.37e-05	0.000426	CcSEcCtD
Ergonovine—Diarrhoea—Dexamethasone—hematologic cancer	8.37e-05	0.000426	CcSEcCtD
Ergonovine—Palpitations—Doxorubicin—hematologic cancer	8.35e-05	0.000425	CcSEcCtD
Ergonovine—Hypotension—Methotrexate—hematologic cancer	8.32e-05	0.000423	CcSEcCtD
Ergonovine—Shock—Epirubicin—hematologic cancer	8.19e-05	0.000417	CcSEcCtD
Ergonovine—Hypertension—Doxorubicin—hematologic cancer	8.15e-05	0.000415	CcSEcCtD
Ergonovine—Dizziness—Betamethasone—hematologic cancer	8.09e-05	0.000411	CcSEcCtD
Ergonovine—Dizziness—Dexamethasone—hematologic cancer	8.09e-05	0.000411	CcSEcCtD
Ergonovine—Hyperhidrosis—Epirubicin—hematologic cancer	8.05e-05	0.00041	CcSEcCtD
Ergonovine—Chest pain—Doxorubicin—hematologic cancer	8.04e-05	0.000409	CcSEcCtD
Ergonovine—Nausea—Triamcinolone—hematologic cancer	8.01e-05	0.000407	CcSEcCtD
Ergonovine—Dyspnoea—Methotrexate—hematologic cancer	7.94e-05	0.000404	CcSEcCtD
Ergonovine—Hypotension—Epirubicin—hematologic cancer	7.78e-05	0.000396	CcSEcCtD
Ergonovine—Vomiting—Dexamethasone—hematologic cancer	7.78e-05	0.000396	CcSEcCtD
Ergonovine—Vomiting—Betamethasone—hematologic cancer	7.78e-05	0.000396	CcSEcCtD
Ergonovine—Headache—Dexamethasone—hematologic cancer	7.66e-05	0.00039	CcSEcCtD
Ergonovine—Headache—Betamethasone—hematologic cancer	7.66e-05	0.00039	CcSEcCtD
Ergonovine—Shock—Doxorubicin—hematologic cancer	7.58e-05	0.000386	CcSEcCtD
Ergonovine—Hyperhidrosis—Doxorubicin—hematologic cancer	7.45e-05	0.000379	CcSEcCtD
Ergonovine—Dyspnoea—Epirubicin—hematologic cancer	7.43e-05	0.000378	CcSEcCtD
Ergonovine—Diarrhoea—Prednisone—hematologic cancer	7.29e-05	0.000371	CcSEcCtD
Ergonovine—Gastrointestinal pain—Methotrexate—hematologic cancer	7.28e-05	0.00037	CcSEcCtD
Ergonovine—Nausea—Betamethasone—hematologic cancer	7.26e-05	0.00037	CcSEcCtD
Ergonovine—Nausea—Dexamethasone—hematologic cancer	7.26e-05	0.00037	CcSEcCtD
Ergonovine—Hypotension—Doxorubicin—hematologic cancer	7.2e-05	0.000366	CcSEcCtD
Ergonovine—Dizziness—Prednisone—hematologic cancer	7.04e-05	0.000358	CcSEcCtD
Ergonovine—Abdominal pain—Methotrexate—hematologic cancer	7.04e-05	0.000358	CcSEcCtD
Ergonovine—Dyspnoea—Doxorubicin—hematologic cancer	6.87e-05	0.00035	CcSEcCtD
Ergonovine—Gastrointestinal pain—Epirubicin—hematologic cancer	6.81e-05	0.000346	CcSEcCtD
Ergonovine—Vomiting—Prednisone—hematologic cancer	6.77e-05	0.000344	CcSEcCtD
Ergonovine—Headache—Prednisone—hematologic cancer	6.67e-05	0.000339	CcSEcCtD
Ergonovine—Abdominal pain—Epirubicin—hematologic cancer	6.58e-05	0.000335	CcSEcCtD
Ergonovine—Nausea—Prednisone—hematologic cancer	6.33e-05	0.000322	CcSEcCtD
Ergonovine—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.3e-05	0.000321	CcSEcCtD
Ergonovine—Abdominal pain—Doxorubicin—hematologic cancer	6.09e-05	0.00031	CcSEcCtD
Ergonovine—Diarrhoea—Methotrexate—hematologic cancer	6.09e-05	0.00031	CcSEcCtD
Ergonovine—Dizziness—Methotrexate—hematologic cancer	5.89e-05	0.000299	CcSEcCtD
Ergonovine—Diarrhoea—Epirubicin—hematologic cancer	5.7e-05	0.00029	CcSEcCtD
Ergonovine—Vomiting—Methotrexate—hematologic cancer	5.66e-05	0.000288	CcSEcCtD
Ergonovine—Headache—Methotrexate—hematologic cancer	5.58e-05	0.000284	CcSEcCtD
Ergonovine—Dizziness—Epirubicin—hematologic cancer	5.51e-05	0.00028	CcSEcCtD
Ergonovine—Vomiting—Epirubicin—hematologic cancer	5.3e-05	0.000269	CcSEcCtD
Ergonovine—Nausea—Methotrexate—hematologic cancer	5.29e-05	0.000269	CcSEcCtD
Ergonovine—Diarrhoea—Doxorubicin—hematologic cancer	5.27e-05	0.000268	CcSEcCtD
Ergonovine—Headache—Epirubicin—hematologic cancer	5.22e-05	0.000265	CcSEcCtD
Ergonovine—Dizziness—Doxorubicin—hematologic cancer	5.1e-05	0.000259	CcSEcCtD
Ergonovine—Nausea—Epirubicin—hematologic cancer	4.95e-05	0.000252	CcSEcCtD
Ergonovine—Vomiting—Doxorubicin—hematologic cancer	4.9e-05	0.000249	CcSEcCtD
Ergonovine—Headache—Doxorubicin—hematologic cancer	4.83e-05	0.000246	CcSEcCtD
Ergonovine—Nausea—Doxorubicin—hematologic cancer	4.58e-05	0.000233	CcSEcCtD
Ergonovine—HTR1E—Signaling by GPCR—IL6—hematologic cancer	9.1e-06	0.000167	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—FHL2—hematologic cancer	9.08e-06	0.000167	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTT1—hematologic cancer	9.03e-06	0.000166	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD86—hematologic cancer	8.98e-06	0.000165	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	8.96e-06	0.000165	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—JAK2—hematologic cancer	8.93e-06	0.000164	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCND1—hematologic cancer	8.92e-06	0.000164	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AGRN—hematologic cancer	8.9e-06	0.000164	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—JUN—hematologic cancer	8.9e-06	0.000164	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HES1—hematologic cancer	8.86e-06	0.000163	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	8.86e-06	0.000163	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SDC1—hematologic cancer	8.83e-06	0.000162	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NCOR1—hematologic cancer	8.81e-06	0.000162	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.77e-06	0.000161	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	8.77e-06	0.000161	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	8.74e-06	0.000161	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CSF2—hematologic cancer	8.71e-06	0.00016	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF1—hematologic cancer	8.71e-06	0.00016	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CDKN1A—hematologic cancer	8.63e-06	0.000159	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTEN—hematologic cancer	8.61e-06	0.000158	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	8.6e-06	0.000158	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FOXO1—hematologic cancer	8.58e-06	0.000158	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2—hematologic cancer	8.58e-06	0.000158	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFRB—hematologic cancer	8.57e-06	0.000157	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CB—hematologic cancer	8.48e-06	0.000156	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.46e-06	0.000155	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—IDH2—hematologic cancer	8.44e-06	0.000155	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMMR—hematologic cancer	8.44e-06	0.000155	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFRA—hematologic cancer	8.43e-06	0.000155	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK8—hematologic cancer	8.42e-06	0.000155	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PRKCG—hematologic cancer	8.41e-06	0.000154	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAK1—hematologic cancer	8.41e-06	0.000154	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—AKT1—hematologic cancer	8.4e-06	0.000154	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	8.36e-06	0.000154	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	8.33e-06	0.000153	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	8.29e-06	0.000152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	8.28e-06	0.000152	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	8.27e-06	0.000152	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EP300—hematologic cancer	8.21e-06	0.000151	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	8.15e-06	0.00015	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SRC—hematologic cancer	7.98e-06	0.000147	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	7.96e-06	0.000146	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	7.94e-06	0.000146	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.94e-06	0.000146	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.92e-06	0.000146	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	7.9e-06	0.000145	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2RA—hematologic cancer	7.85e-06	0.000144	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	7.81e-06	0.000144	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—hematologic cancer	7.79e-06	0.000143	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—hematologic cancer	7.77e-06	0.000143	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TERT—hematologic cancer	7.76e-06	0.000143	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CA9—hematologic cancer	7.72e-06	0.000142	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ACP5—hematologic cancer	7.72e-06	0.000142	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—hematologic cancer	7.7e-06	0.000141	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NRAS—hematologic cancer	7.68e-06	0.000141	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD86—hematologic cancer	7.64e-06	0.00014	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.62e-06	0.00014	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	7.59e-06	0.00014	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDGFB—hematologic cancer	7.58e-06	0.000139	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HES1—hematologic cancer	7.53e-06	0.000138	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CD44—hematologic cancer	7.51e-06	0.000138	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NQO1—hematologic cancer	7.51e-06	0.000138	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	7.49e-06	0.000138	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	7.4e-06	0.000136	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TSC2—hematologic cancer	7.4e-06	0.000136	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	7.4e-06	0.000136	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK3—hematologic cancer	7.35e-06	0.000135	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	7.3e-06	0.000134	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	7.29e-06	0.000134	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	7.28e-06	0.000134	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—IDH1—hematologic cancer	7.26e-06	0.000133	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	7.21e-06	0.000133	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.18e-06	0.000132	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—TXN—hematologic cancer	7.18e-06	0.000132	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.18e-06	0.000132	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	7.17e-06	0.000132	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—hematologic cancer	7.15e-06	0.000131	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	7.15e-06	0.000131	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	7.15e-06	0.000131	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—hematologic cancer	7.14e-06	0.000131	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGFR3—hematologic cancer	7.12e-06	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYCS—hematologic cancer	7.1e-06	0.000131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.06e-06	0.00013	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK14—hematologic cancer	7.05e-06	0.00013	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.02e-06	0.000129	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ESR1—hematologic cancer	6.92e-06	0.000127	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FN1—hematologic cancer	6.83e-06	0.000126	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BAD—hematologic cancer	6.75e-06	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NFKBIA—hematologic cancer	6.75e-06	0.000124	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.75e-06	0.000124	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOTCH1—hematologic cancer	6.69e-06	0.000123	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	6.67e-06	0.000123	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	6.62e-06	0.000122	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KRAS—hematologic cancer	6.61e-06	0.000121	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TERT—hematologic cancer	6.6e-06	0.000121	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.57e-06	0.000121	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.57e-06	0.000121	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD80—hematologic cancer	6.55e-06	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CG—hematologic cancer	6.54e-06	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KIT—hematologic cancer	6.54e-06	0.00012	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—NRAS—hematologic cancer	6.54e-06	0.00012	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	6.44e-06	0.000118	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTPN11—hematologic cancer	6.42e-06	0.000118	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.4e-06	0.000118	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	6.3e-06	0.000116	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK3—hematologic cancer	6.26e-06	0.000115	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTP1—hematologic cancer	6.26e-06	0.000115	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CREB1—hematologic cancer	6.23e-06	0.000114	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NUP98—hematologic cancer	6.2e-06	0.000114	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—BRAF—hematologic cancer	6.15e-06	0.000113	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL2—hematologic cancer	6.09e-06	0.000112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6R—hematologic cancer	6.07e-06	0.000112	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PIK3CA—hematologic cancer	6.07e-06	0.000112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CREBBP—hematologic cancer	6.06e-06	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	6.06e-06	0.000111	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.02e-06	0.000111	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.02e-06	0.000111	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	6e-06	0.00011	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.97e-06	0.00011	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	5.88e-06	0.000108	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—hematologic cancer	5.87e-06	0.000108	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTR—hematologic cancer	5.85e-06	0.000108	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.85e-06	0.000108	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FN1—hematologic cancer	5.81e-06	0.000107	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAP2K1—hematologic cancer	5.79e-06	0.000106	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—hematologic cancer	5.75e-06	0.000106	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NCOR1—hematologic cancer	5.75e-06	0.000106	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CD—hematologic cancer	5.75e-06	0.000106	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	5.74e-06	0.000106	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BAD—hematologic cancer	5.74e-06	0.000106	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ENO2—hematologic cancer	5.74e-06	0.000105	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PIK3CA—hematologic cancer	5.69e-06	0.000105	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	5.69e-06	0.000105	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—KRAS—hematologic cancer	5.63e-06	0.000103	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HRAS—hematologic cancer	5.62e-06	0.000103	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD80—hematologic cancer	5.57e-06	0.000102	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.57e-06	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	5.56e-06	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KIT—hematologic cancer	5.56e-06	0.000102	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	5.56e-06	0.000102	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FGF2—hematologic cancer	5.5e-06	0.000101	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	5.46e-06	0.0001	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SDC1—hematologic cancer	5.44e-06	0.0001	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3R1—hematologic cancer	5.43e-06	9.98e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—hematologic cancer	5.38e-06	9.88e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	5.33e-06	9.79e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	5.29e-06	9.73e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JAK2—hematologic cancer	5.28e-06	9.7e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	5.23e-06	9.61e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	5.18e-06	9.52e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PIK3CA—hematologic cancer	5.17e-06	9.5e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	5.16e-06	9.49e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	5.16e-06	9.48e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MDM2—hematologic cancer	5.15e-06	9.47e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—MTHFR—hematologic cancer	5.09e-06	9.35e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MTOR—hematologic cancer	5.01e-06	9.21e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CB—hematologic cancer	5.01e-06	9.21e-05	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—AKT1—hematologic cancer	4.96e-06	9.12e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	4.92e-06	9.04e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	4.89e-06	8.98e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	4.84e-06	8.9e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	4.79e-06	8.8e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	4.78e-06	8.79e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	4.7e-06	8.64e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	4.68e-06	8.6e-05	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	4.65e-06	8.55e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CD44—hematologic cancer	4.63e-06	8.5e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.63e-06	8.5e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	4.62e-06	8.48e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CASP3—hematologic cancer	4.61e-06	8.47e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—hematologic cancer	4.6e-06	8.46e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—hematologic cancer	4.58e-06	8.42e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCND1—hematologic cancer	4.49e-06	8.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	4.49e-06	8.25e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—JUN—hematologic cancer	4.48e-06	8.23e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	4.4e-06	8.08e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	4.38e-06	8.05e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYCS—hematologic cancer	4.38e-06	8.04e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.35e-06	7.99e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	4.34e-06	7.98e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTEN—hematologic cancer	4.33e-06	7.96e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.27e-06	7.85e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	4.26e-06	7.83e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	4.26e-06	7.83e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	4.24e-06	7.79e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	4.22e-06	7.76e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EP300—hematologic cancer	4.13e-06	7.59e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	4.07e-06	7.48e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SRC—hematologic cancer	4.02e-06	7.38e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	4e-06	7.35e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.96e-06	7.28e-05	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	3.96e-06	7.27e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	3.92e-06	7.2e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	3.91e-06	7.19e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	3.91e-06	7.19e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	3.89e-06	7.16e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	3.87e-06	7.12e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	3.86e-06	7.1e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.86e-06	7.09e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	3.81e-06	7.01e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	3.81e-06	7e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.76e-06	6.9e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—hematologic cancer	3.71e-06	6.82e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	3.7e-06	6.8e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	3.69e-06	6.78e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	3.68e-06	6.77e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.65e-06	6.71e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	3.6e-06	6.62e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—hematologic cancer	3.6e-06	6.61e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	3.59e-06	6.6e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	3.59e-06	6.6e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.55e-06	6.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.55e-06	6.52e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.55e-06	6.52e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	3.51e-06	6.45e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	3.41e-06	6.28e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	3.33e-06	6.11e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	3.32e-06	6.11e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	3.29e-06	6.05e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	3.28e-06	6.04e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.27e-06	6.02e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	3.15e-06	5.78e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.13e-06	5.76e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	3.06e-06	5.62e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	3.05e-06	5.61e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	3.05e-06	5.61e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.96e-06	5.43e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PTEN—hematologic cancer	2.83e-06	5.2e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	2.83e-06	5.2e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.83e-06	5.19e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.71e-06	4.97e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—EP300—hematologic cancer	2.7e-06	4.96e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.63e-06	4.84e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	2.6e-06	4.77e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	2.51e-06	4.62e-05	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	2.5e-06	4.59e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.44e-06	4.49e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	2.4e-06	4.42e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.31e-06	4.25e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	2.3e-06	4.23e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—hematologic cancer	2.28e-06	4.2e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.19e-06	4.02e-05	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	2.12e-06	3.9e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.02e-06	3.71e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—PIK3CA—hematologic cancer	2e-06	3.67e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.74e-06	3.2e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—EP300—hematologic cancer	1.66e-06	3.06e-05	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AKT1—hematologic cancer	1.63e-06	3e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.23e-06	2.26e-05	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AKT1—hematologic cancer	1e-06	1.85e-05	CbGpPWpGaD
